advertisement
Abstract #13488 Published in IGR 8-1
Increased glutamate uptake and GLAST expression by cyclic AMP in retinal glial cells
Sakai T; Yoshitoshi T; Nagai Y; Kitahara KGraefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 359-363
BACKGROUND: The aim was to investigate the effect of cyclic adenosine monophosphate (cAMP) on glutamate uptake and glial glutamate aspartate transporter (GLAST) expression in cultured rat retinal glial cells. METHODS: Retinal glial cell cultures were prepared from 1- to 3-day-old Sprague-Dawley rats. Cultures were treated with dibutyryl-cAMP (dBcAMP) for 24 h. Glutamate uptake was measured as (3)H-glutamate content of the lysates as determined by scintillation counting. The expression of GLAST in dBcAMP-treated cells was examined by semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting. RESULTS: Cells were identified by immunocytochemistry using antibodies against vimentin and carbonic anhydrase C. Treatment of cultured cells with dBcAMP significantly increased glutamate uptake after 60 min compared with untreated cells (p < 0.01). Maintenance of cells in medium supplemented with dBcAMP increased GLAST mRNA and protein levels. GLAST mRNA levels were elevated 2.9-fold 24 h after treatment. GLAST protein levels were elevated 2.5-fold 24 h after treatment. CONCLUSIONS: These results indicate that treatment with cAMP increases glutamate uptake through upregulated GLAST activity in cultured retinal glial cells. These findings suggest that retinal glial cells may regulate extracellular glutamate concentration and protect retinal neurons against glutamate excitotoxicity.
Dr. T. Sakai, Department of Ophthalmology, Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-ku, Tokyo, 105-8461, Japan. tstmski@jikei.ac.jp
Classification:
11.14 Investigational drugs; pharmacological experiments (Part of: 11 Medical treatment)
